Venmax Drugs & Pharmaceuticals Ltd
₹14.90
as on
What are INDmoney investors doing with Venmax Drugs & Pharmaceuticals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
-22%
Searches for Venmax Drugs & Pharmaceuticals on INDmoney have decreased by 22% over the last 30 days.
Venmax Drugs & Pharmaceuticals Stock Performance
as on September 16, 2026 at 9:31 pm IST
Day's Low
Day's High
₹14.15₹16.20
5.03%
Downside
8.72%
Upside
52 Week's Low
52 Week's High
₹13.52₹31.499.26%
Downside
111.34%
Upside
Venmax Drugs & Pharmaceuticals share price movements today
- Previous Close
- ₹14.99
- Open
- ₹14.15
- Volume
- 385.00
- Upper Circuit
- ₹17.98
- Lower Circuit
- ₹12.00
- Day's Low - High
- ₹14.15 - ₹16.20
- 52 Week Low - High
- ₹13.52 - ₹31.49
Venmax Drugs & Pharmaceuticals Historical Returns
- 1 Month Return
- -8.93 %
- 3 Month Return
- -28.92 %
- 1 Year Return
- -39.48 %
- 3 Year Return
- + 127.81 %
- 5 Year Return
- + 127.81 %
Venmax Drugs & Pharmaceuticals Fundamentals
as on September 16, 2026 at 4:01 pm IST
Market Cap
₹21.71 Cr
Return on Equity (ROE)
2.07
PE Ratio (TTM)
37.07
Return on capital employed (ROCE)
2.28
Industry PE ratio
51.81
Beta (LTM)
0.59
P/B Ratio
2.43
Dividend Yield
0PEG Ratio
97.56
Quarterly Earnings Growth YOY
200
EPS (TTM)
0Book Value
0Venmax Drugs & Pharmaceuticals Stock Valuation
as on September 16, 2026 at 4:01 pm IST
Venmax Drugs & Pharmaceuticals in the last 5 years
Lowest (-1543.00x)
April 4, 2025
Today (37.07x)
September 11, 2026
Industry (51.81x)
September 11, 2026
Highest (1176.33x)
August 26, 2025
Today’s Price to Earnings Ratio: 37.07x
Venmax Drugs & Pharmaceuticals Technical Analysis
Track how Venmax Drugs & Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -0.02 | |
CCI (20) | -121.68 | Bullish |
RSI (14) | 0 | Bullish |
Momentum (10) | -0.1 | Neutral |
ADI (14) | 90.52 | |
Ultimate Oscillator (7,14,28) | 50.7 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 14.98 | |
EMA (20) | 14.97 | |
VWMA (20) | 14.96 | |
SMA (50) | 14.99 | |
EMA (50) | 15 | |
SMA (200) | 15.38 | |
EMA (200) | 15.29 | |
KAMA (200) | 14.91 | |
DEMA (200) | 14.97 |
Venmax Drugs & Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Venmax Drugs & Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 21.71 | 25.56% | 0.00 | -1 | 8 | |
| NA | 29.19 | 47.69% | 0.00 | 1 | NA | |
| BUY | 15,409.97 | 11.25% | 0.50 | 259 | 1,054 | |
| NA | 11.79 | 21.54% | 0.00 | -1 | 21 | |
| HOLD | 14,671.79 | -3.06% | 0.54 | 1,371 | 4,078 |
Venmax Drugs & Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Venmax Drugs & Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Venmax Drugs & Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Venmax Drugs & Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Venmax Drugs & Pharmaceuticals.
Venmax Drugs & Pharmaceuticals Ltd Earnings Results
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 200% since last year same period to ₹0.12Cr in the Q1 2026-2027. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated 9.09% jump in its net profits since last 3-months.
Read More about Earnings Results
Insights on Venmax Drugs & Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, Venmax Drugs stock has moved up by 5.3%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 86.20% to 89.54% in Jun 2026 quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 90.3%
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 13.80% to 10.46% in Jun 2026 quarter
About Venmax Drugs & Pharmaceuticals Ltd
Revenue: ₹2.48Cr as on June 2026 (Q1 FY27)
Net Profit: ₹0.12Cr as on June 2026 (Q1 FY27)
| Organisation | Venmax Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Venmax Drugs & Pharmaceuticals share price today?
Venmax Drugs & Pharmaceuticals share price today stands at ₹14.9 as on at the close of the market. Venmax Drugs & Pharmaceuticals share today touched a day high of ₹16.2 and a low of ₹14.15.
What is the 52 week high and 52 week low range for Venmax Drugs & Pharmaceuticals share?
Venmax Drugs & Pharmaceuticals touched a 52 week high of ₹31.49 and a 52 week low of ₹13.52. Venmax Drugs & Pharmaceuticals share price today i.e. is closed at ₹14.9, which is -52.68% down from its 52 week high and 10.21% up from its 52 week low.
What is Venmax Drugs & Pharmaceuticals's market capitalisation today?
Venmax Drugs & Pharmaceuticals market capitalisation is ₹21.71 Cr as on .
How to buy Venmax Drugs & Pharmaceuticals shares?
To buy Venmax Drugs & Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 531015 or Venmax Drugs & Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Venmax Drugs & Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Venmax Drugs & Pharmaceuticals trading volume today?
Venmax Drugs & Pharmaceuticals trading volume is 385.00 as on . This means that 385.00 shares of Venmax Drugs & Pharmaceuticals were bought and sold on the stock market during today's trading session.